Advestra advised Cactus life sciences, a global scientific communications agency that works with blue chip pharma and biotechnology companies, on nspm and eluSCIdate’
Tags :Advestra
Advestra advised UBS on EUR 300 million rights offering by Swiss Steel. The transaction consisted in an offering of subscription rights and a placement of shares on which rights
DocMorris (former Zur Rose Group) successfully placed CHF 200 million senior unsecured guaranteed convertible bonds due 2029. The bonds were issued by a Dutch subsi
Meyer Burger Technology has successfully completed a capital increase raising gross proceeds of approximately CHF 207 million. The transaction con
Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company pioneering allosteric modulation-based drug development,
Swiss Prime Site has successfully placed green bonds in the aggregate principal amount of of CHF 250 million 1.80% due 2030. The bonds were issued by Swiss Prime Site Finance AG
Kinarus Therapeutics Holding AG (“Kinarus”) and Curatis AG (“Curatis”), announced they have signed a binding agreement to combine their businesses, by way of an exchange of Curatis shares
Barry Callebaut tapped the Swiss market for the first time successfully issuing two tranches of CHF bonds in the total aggregate amount of CHF 600 million. The first tranche
ams-OSRAM successfully completed its holistic financing plan, which consisted, among others, of a rights offering and the placement of high-yield bonds. In connec
In a strategic move to enrich its historical legacy, Breitling has successfully acquired Universal Genève, a distinguished watchmaking brand. This acquisition represents Breitling’s commitment to preserving and celebrating horological craftsmanship. Universal Genève,
